Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
- PMID: 29942092
- DOI: 10.1038/s41591-018-0078-7
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Erratum in
-
Publisher Correction: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis.Nat Med. 2018 Dec;24(12):1941. doi: 10.1038/s41591-018-0176-6. Nat Med. 2018. PMID: 30135555
Abstract
The quantity of tumor-infiltrating lymphocytes (TILs) in breast cancer (BC) is a robust prognostic factor for improved patient survival, particularly in triple-negative and HER2-overexpressing BC subtypes1. Although T cells are the predominant TIL population2, the relationship between quantitative and qualitative differences in T cell subpopulations and patient prognosis remains unknown. We performed single-cell RNA sequencing (scRNA-seq) of 6,311 T cells isolated from human BCs and show that significant heterogeneity exists in the infiltrating T cell population. We demonstrate that BCs with a high number of TILs contained CD8+ T cells with features of tissue-resident memory T (TRM) cell differentiation and that these CD8+ TRM cells expressed high levels of immune checkpoint molecules and effector proteins. A CD8+ TRM gene signature developed from the scRNA-seq data was significantly associated with improved patient survival in early-stage triple-negative breast cancer (TNBC) and provided better prognostication than CD8 expression alone. Our data suggest that CD8+ TRM cells contribute to BC immunosurveillance and are the key targets of modulation by immune checkpoint inhibition. Further understanding of the development, maintenance and regulation of TRM cells will be crucial for successful immunotherapeutic development in BC.
Comment in
-
Sequencing cells of the immune TME.Nat Rev Clin Oncol. 2018 Sep;15(9):531. doi: 10.1038/s41571-018-0069-0. Nat Rev Clin Oncol. 2018. PMID: 29985469 No abstract available.
-
Resident Breast T Cells: The Troops Are Already There.Trends Mol Med. 2018 Oct;24(10):821-822. doi: 10.1016/j.molmed.2018.07.006. Epub 2018 Aug 1. Trends Mol Med. 2018. PMID: 30077643 Free PMC article.
Similar articles
-
Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.Histopathology. 2018 Dec;73(6):887-896. doi: 10.1111/his.13695. Epub 2018 Oct 9. Histopathology. 2018. PMID: 29947077
-
Tissue-resident memory T cells in breast cancer control and immunotherapy responses.Nat Rev Clin Oncol. 2020 Jun;17(6):341-348. doi: 10.1038/s41571-020-0333-y. Epub 2020 Feb 28. Nat Rev Clin Oncol. 2020. PMID: 32112054 Review.
-
Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.Clin Breast Cancer. 2016 Feb;16(1):51-8. doi: 10.1016/j.clbc.2015.07.006. Epub 2015 Aug 6. Clin Breast Cancer. 2016. PMID: 26364145
-
Tumoral PD-1hiCD8+ T cells are partially exhausted and predict favorable outcome in triple-negative breast cancer.Clin Sci (Lond). 2020 Apr 17;134(7):711-726. doi: 10.1042/CS20191261. Clin Sci (Lond). 2020. PMID: 32202617
-
The potential role of CD8+ cytotoxic T lymphocytes and one branch connected with tissue-resident memory in non-luminal breast cancer.PeerJ. 2024 Jul 10;12:e17667. doi: 10.7717/peerj.17667. eCollection 2024. PeerJ. 2024. PMID: 39006029 Free PMC article. Review.
Cited by
-
Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.J Clin Invest. 2021 Apr 1;131(7):e143729. doi: 10.1172/JCI143729. J Clin Invest. 2021. PMID: 33792560 Free PMC article.
-
Cellular networks controlling T cell persistence in adoptive cell therapy.Nat Rev Immunol. 2021 Dec;21(12):769-784. doi: 10.1038/s41577-021-00539-6. Epub 2021 Apr 20. Nat Rev Immunol. 2021. PMID: 33879873 Review.
-
NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer.J Exp Clin Cancer Res. 2024 Jan 3;43(1):10. doi: 10.1186/s13046-023-02918-4. J Exp Clin Cancer Res. 2024. PMID: 38167224 Free PMC article.
-
BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer.Oncogene. 2021 Apr;40(16):2982-2997. doi: 10.1038/s41388-021-01756-y. Epub 2021 Mar 25. Oncogene. 2021. PMID: 33767438
-
Identification of the novel exhausted T cell CD8 + markers in breast cancer.Sci Rep. 2024 Aug 19;14(1):19142. doi: 10.1038/s41598-024-70184-1. Sci Rep. 2024. PMID: 39160211 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous